HUMANIGEN, INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Humanigen, Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2022.
  • Humanigen, Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $171M, a 13.8% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $171M +$20.7M +13.8% Dec 31, 2022 10-K 2023-03-30
Q4 2021 $151M +$68.2M +82.7% Dec 31, 2021 10-K 2023-03-30
Q4 2020 $82.4M +$25M +43.6% Dec 31, 2020 10-K 2022-03-01
Q4 2019 $57.4M +$2.67M +4.88% Dec 31, 2019 10-K 2021-03-10
Q4 2018 $54.8M +$3.15M +6.11% Dec 31, 2018 10-K 2020-03-16
Q4 2017 $51.6M -$12.6M -19.6% Dec 31, 2017 10-K 2019-03-26
Q4 2016 $64.2M +$10.5M +19.5% Dec 31, 2016 10-K 2018-03-27
Q4 2015 $53.7M +$12.3M +29.7% Dec 31, 2015 10-K 2017-03-09
Q4 2014 $41.4M -$15.4M -27.1% Dec 31, 2014 10-K 2016-09-01
Q4 2013 $56.8M +$16.6M +41.2% Dec 31, 2013 10-K 2015-03-16
Q4 2012 $40.2M +$9.16M +29.5% Dec 31, 2012 10-K 2014-03-13
Q4 2011 $31M Dec 31, 2011 10-K 2013-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.